A Perspective for Ménière’s Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2

Ménière’s disease is a chronic illness characterized by intermittent episodes of vertigo associated with fluctuating sensorineural hearing loss, tinnitus and aural pressure. This pathology strongly correlates with a dilatation of the fluid compartment of the endolymph, so-called hydrops. Dexamethaso...

Full description

Bibliographic Details
Main Authors: Robin Mom, Julien Robert-Paganin, Thierry Mom, Christian Chabbert, Stéphane Réty, Daniel Auguin
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/4/511
_version_ 1827621647222308864
author Robin Mom
Julien Robert-Paganin
Thierry Mom
Christian Chabbert
Stéphane Réty
Daniel Auguin
author_facet Robin Mom
Julien Robert-Paganin
Thierry Mom
Christian Chabbert
Stéphane Réty
Daniel Auguin
author_sort Robin Mom
collection DOAJ
description Ménière’s disease is a chronic illness characterized by intermittent episodes of vertigo associated with fluctuating sensorineural hearing loss, tinnitus and aural pressure. This pathology strongly correlates with a dilatation of the fluid compartment of the endolymph, so-called hydrops. Dexamethasone is one of the therapeutic approaches recommended when conventional antivertigo treatments have failed. Several mechanisms of actions have been hypothesized for the mode of action of dexamethasone, such as the anti-inflammatory effect or as a regulator of inner ear water homeostasis. However, none of them have been experimentally confirmed so far. Aquaporins (AQPs) are transmembrane water channels and are hence central in the regulation of transcellular water fluxes. In the present study, we investigated the hypothesis that dexamethasone could impact water fluxes in the inner ear by targeting AQP2. We addressed this question through molecular dynamics simulations approaches and managed to demonstrate a direct interaction between AQP2 and dexamethasone and its significant impact on the channel water permeability. Through compartmentalization of sodium and potassium ions, a significant effect of Na+ upon AQP2 water permeability was highlighted as well. The molecular mechanisms involved in dexamethasone binding and in its regulatory action upon AQP2 function are described.
first_indexed 2024-03-09T11:06:18Z
format Article
id doaj.art-959f4e3f6c77463f836dbcc47c0d9497
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T11:06:18Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-959f4e3f6c77463f836dbcc47c0d94972023-12-01T00:55:36ZengMDPI AGBiomolecules2218-273X2022-03-0112451110.3390/biom12040511A Perspective for Ménière’s Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2Robin Mom0Julien Robert-Paganin1Thierry Mom2Christian Chabbert3Stéphane Réty4Daniel Auguin5Research Group on Vestibular Pathophysiology, CNRS, Unit GDR2074, F-13331 Marseille, FranceStructural Motility, Institut Curie, Paris Université Sciences et Lettres, Sorbonne Université, CNRS UMR144, F-75005 Paris, FranceResearch Group on Vestibular Pathophysiology, CNRS, Unit GDR2074, F-13331 Marseille, FranceResearch Group on Vestibular Pathophysiology, CNRS, Unit GDR2074, F-13331 Marseille, FranceLaboratoire de Biologie et Modélisation de la Cellule, ENS de Lyon, University Claude Bernard, CNRS UMR 5239, INSERM U1210, 46 Allée d’Italie Site Jacques Monod, F-69007 Lyon, FranceStructural Motility, Institut Curie, Paris Université Sciences et Lettres, Sorbonne Université, CNRS UMR144, F-75005 Paris, FranceMénière’s disease is a chronic illness characterized by intermittent episodes of vertigo associated with fluctuating sensorineural hearing loss, tinnitus and aural pressure. This pathology strongly correlates with a dilatation of the fluid compartment of the endolymph, so-called hydrops. Dexamethasone is one of the therapeutic approaches recommended when conventional antivertigo treatments have failed. Several mechanisms of actions have been hypothesized for the mode of action of dexamethasone, such as the anti-inflammatory effect or as a regulator of inner ear water homeostasis. However, none of them have been experimentally confirmed so far. Aquaporins (AQPs) are transmembrane water channels and are hence central in the regulation of transcellular water fluxes. In the present study, we investigated the hypothesis that dexamethasone could impact water fluxes in the inner ear by targeting AQP2. We addressed this question through molecular dynamics simulations approaches and managed to demonstrate a direct interaction between AQP2 and dexamethasone and its significant impact on the channel water permeability. Through compartmentalization of sodium and potassium ions, a significant effect of Na+ upon AQP2 water permeability was highlighted as well. The molecular mechanisms involved in dexamethasone binding and in its regulatory action upon AQP2 function are described.https://www.mdpi.com/2218-273X/12/4/511human AQP2dexamethasoneMénière’s diseasewater channelwater permeability modulationmolecular dynamics
spellingShingle Robin Mom
Julien Robert-Paganin
Thierry Mom
Christian Chabbert
Stéphane Réty
Daniel Auguin
A Perspective for Ménière’s Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2
Biomolecules
human AQP2
dexamethasone
Ménière’s disease
water channel
water permeability modulation
molecular dynamics
title A Perspective for Ménière’s Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2
title_full A Perspective for Ménière’s Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2
title_fullStr A Perspective for Ménière’s Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2
title_full_unstemmed A Perspective for Ménière’s Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2
title_short A Perspective for Ménière’s Disease: In Silico Investigations of Dexamethasone as a Direct Modulator of AQP2
title_sort perspective for meniere s disease in silico investigations of dexamethasone as a direct modulator of aqp2
topic human AQP2
dexamethasone
Ménière’s disease
water channel
water permeability modulation
molecular dynamics
url https://www.mdpi.com/2218-273X/12/4/511
work_keys_str_mv AT robinmom aperspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT julienrobertpaganin aperspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT thierrymom aperspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT christianchabbert aperspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT stephanerety aperspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT danielauguin aperspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT robinmom perspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT julienrobertpaganin perspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT thierrymom perspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT christianchabbert perspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT stephanerety perspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2
AT danielauguin perspectiveformenieresdiseaseinsilicoinvestigationsofdexamethasoneasadirectmodulatorofaqp2